Results 61 to 70 of about 319,380 (216)

Translational perspectives on psoriatic arthritis. [PDF]

open access: yes, 2009
The term psoriatic disease encompasses the array of disorders (arthritis, inflammatory bowel disease, uveitis, obesity, metabolic syndrome, type II diabetes, and cardiovascular disease) that are associated with psoriasis.
Proulx, Steven T   +2 more
core   +1 more source

Rehabilitation in Psoriatic Arthritis

open access: yes, 2009
This article summarizes the state of the art of rehabilitation in psoriatic arthritis (PsA). Very little evidence was available to assess the efficacy of rehabilitation. Some data were borrowed from Studies on ankylosing spondylitis.
M. Atteno   +4 more
core   +2 more sources

PTPN22 is associated with susceptibility to psoriatic arthritis but not psoriasis: evidence for a further PsA-specific risk locus [PDF]

open access: yesAnnals of the Rheumatic Diseases, 2015
Psoriatic arthritis (PsA) is a chronic inflammatory arthritis associated with psoriasis; it has a higher estimated genetic component than psoriasis alone, however most genetic susceptibility loci identified for PsA to date are also shared with psoriasis.
Bowes, J.   +23 more
openaire   +8 more sources

Risk of Cancer According to Duration of Targeted Therapy Exposure in Spondyloarthritis: A Nationwide Cohort Study From the French Health Insurance Database

open access: yesArthritis &Rheumatology, EarlyView.
Objective To assess the association between duration of targeted therapy exposure and cancer risk in patients with spondyloarthritis (SpA), including those with psoriatic arthritis, axial SpA, and other subtypes. Methods This nationwide cohort study used the French health insurance database to identify adults with SpA initiating a targeted therapy ...
Karine Tankovic   +7 more
wiley   +1 more source

Treatment Patterns and Pathways of Systemic Drug Therapy in Patients With Plaque, Erythrodermic, and Generalized Pustular Psoriasis: A Retrospective Cohort Study in Japan

open access: yesThe Journal of Dermatology, EarlyView.
ABSTRACT Systemic psoriasis treatment options have rapidly expanded in Japan, including the approval of tyrosine kinase 2 and interleukin‐36 receptor inhibitors in 2022. However, contemporary real‐world treatment patterns across plaque, erythrodermic, and generalized pustular psoriasis remain incompletely characterized.
Yayoi Tada   +9 more
wiley   +1 more source

Group for Research and Assessment of Psoriasis and Psoriatic Arthritis 2015 treatment recommendations for psoriatic arthritis

open access: yes, 2016
Objective: To update the 2009 Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) treatment recommendations for the spectrum of manifestations affecting patients with psoriatic arthritis (PsA). Methods: GRAPPA rheumatologists,
Acosta-Felquer, Maria Laura   +14 more
core   +1 more source

Early detection to improve outcome in people with undiagnosed psoriatic arthritis: the PROMPT research programme including RCT

open access: yesProgramme Grants for Applied Research
Background Longitudinal observational studies suggest that patients who present early to secondary care with psoriatic arthritis have a better outcome. Outcome needs to be measured including domains important to patients.
Neil McHugh   +19 more
doaj   +1 more source

Role of serum and urinary orsomucoid protein A in psoriatic arthritis patients and their relation to disease activity. [PDF]

open access: yesZagazig University Medical Journal
Background: The musculoskeletal disorder known as psoriatic arthritis (PsA) is heterogeneous and can cause a range of symptoms, such as axial involvement, dactylitis, enthesitis, and arthritis. For as many as thirty percent of patients, psoriasis or nail
Adlia Abdelhady   +3 more
doaj   +1 more source

Economic burden of hidradenitis suppurativa based on healthcare resource utilization: German claims data analysis

open access: yesJDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Summary Background and Objectives Hidradenitis suppurativa (HS) is a chronic, debilitating skin disease affecting approximately 0.1% of the German population. Patients with HS require substantial healthcare resource utilization. This study aimed to assess the economic burden associated with HS in Germany.
Falk G. Bechara   +7 more
wiley   +1 more source

Predicting Psoriatic Arthritis in Psoriasis Patients - A Swiss Registry Study.

open access: yes
Background Psoriatic arthritis (PsA) is a prevalent comorbidity among patients with psoriasis, heavily contributing to their burden of disease, usually diagnosed several years after the diagnosis of psoriasis.Objectives To investigate the predictability ...
Wu, Jashin J   +16 more
core   +2 more sources

Home - About - Disclaimer - Privacy